GRACEcast

Are molecular markers just for NSCLC?


Listen Later

Dr. Mary Pinder of Moffitt Cancer Center reviews the CUSTOM trial, in which the study of molecular markers was expanded to patients with small cell lung cancer and thymic carcinomas.

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD